EICHORCondition: Kidney Disease · Kidney Transplantation · Sponsor: Assistance Publique - Hôpitaux de Paris
In clinical nephrology, the search for urinary, blood and tissue biomarkers of specific kidney diseases is an important goal. In recent years, the use of these biomarkers has made it possible to diagnose many renal diseases that affect the native kidney. In some cases, biomarkers may be useful in determining the evolutionary profile of the disease and thus the most appropriate therapeutic management.
This description comes directly from the study's public registry record.
Marie Dr MATIGNON, MD, PhD · 01-49-81-44-51 · marie.matignon@aphp.fr
Vincent Pr AUDARD, MD, PhD · 01 49 81 24 53 · vincent.audard@aphp.fr
Always discuss trial participation with your own doctor first.
| Hôpital Henri Mondor | Créteil, France | Recruiting |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06810258